Skip to main content

Safety and Tolerability of Angiotensin Receptor-Neprilysin Inhibitor Initiation in High-Risk Acute Myocardial Infarction Relative to Care Setting: A Subgroup Analysis of the PARADISE-MI Trial.

Publication ,  Journal Article
De Pasquale, CG; Claggett, B; Jering, K; McMurray, JJV; Mann, D; Miao, ZM; Granger, CB; Køber, L; Maggioni, AP; Rouleau, J-L; Solomon, SD ...
Published in: Circ Heart Fail
July 2024

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Circ Heart Fail

DOI

EISSN

1941-3297

Publication Date

July 2024

Volume

17

Issue

7

Start / End Page

e011393

Location

United States

Related Subject Headings

  • Valsartan
  • Treatment Outcome
  • Tetrazoles
  • Risk Factors
  • Neprilysin
  • Myocardial Infarction
  • Middle Aged
  • Male
  • Humans
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
De Pasquale, C. G., Claggett, B., Jering, K., McMurray, J. J. V., Mann, D., Miao, Z. M., … Pfeffer, M. A. (2024). Safety and Tolerability of Angiotensin Receptor-Neprilysin Inhibitor Initiation in High-Risk Acute Myocardial Infarction Relative to Care Setting: A Subgroup Analysis of the PARADISE-MI Trial. Circ Heart Fail, 17(7), e011393. https://doi.org/10.1161/CIRCHEARTFAILURE.123.011393
De Pasquale, Carmine G., Brian Claggett, Karola Jering, John J. V. McMurray, Douglas Mann, Zi Michael Miao, Christopher B. Granger, et al. “Safety and Tolerability of Angiotensin Receptor-Neprilysin Inhibitor Initiation in High-Risk Acute Myocardial Infarction Relative to Care Setting: A Subgroup Analysis of the PARADISE-MI Trial.Circ Heart Fail 17, no. 7 (July 2024): e011393. https://doi.org/10.1161/CIRCHEARTFAILURE.123.011393.
De Pasquale, Carmine G., et al. “Safety and Tolerability of Angiotensin Receptor-Neprilysin Inhibitor Initiation in High-Risk Acute Myocardial Infarction Relative to Care Setting: A Subgroup Analysis of the PARADISE-MI Trial.Circ Heart Fail, vol. 17, no. 7, July 2024, p. e011393. Pubmed, doi:10.1161/CIRCHEARTFAILURE.123.011393.
De Pasquale CG, Claggett B, Jering K, McMurray JJV, Mann D, Miao ZM, Granger CB, Køber L, Maggioni AP, Rouleau J-L, Solomon SD, Steg PG, van der Meer P, Braunwald E, Pfeffer MA. Safety and Tolerability of Angiotensin Receptor-Neprilysin Inhibitor Initiation in High-Risk Acute Myocardial Infarction Relative to Care Setting: A Subgroup Analysis of the PARADISE-MI Trial. Circ Heart Fail. 2024 Jul;17(7):e011393.

Published In

Circ Heart Fail

DOI

EISSN

1941-3297

Publication Date

July 2024

Volume

17

Issue

7

Start / End Page

e011393

Location

United States

Related Subject Headings

  • Valsartan
  • Treatment Outcome
  • Tetrazoles
  • Risk Factors
  • Neprilysin
  • Myocardial Infarction
  • Middle Aged
  • Male
  • Humans
  • Female